Ensera

Executive Summary

Ensera (formerly SteriPack) is a Poland-based contract design and manufacturing organization (CDMO) specializing in medical devices and pharmaceutical combination products. Founded in 2019 and headquartered in Warsaw, the company provides end-to-end services spanning user-centric design, engineering, sterile manufacturing, packing, and kitting for leading pharmaceutical and medical device companies. Its focus areas include drug delivery, orthopedics, surgical devices, and diagnostics. As a private entity with no disclosed funding rounds, Ensera operates in the high-growth CDMO sector, benefiting from increasing outsourcing trends in the life sciences industry. Given its strategic positioning in Europe and comprehensive service offerings, Ensera is well-placed to capture demand from both established pharma firms and emerging biotech companies. While specific financials remain undisclosed, the company's specialization in sterile and combination products addresses a critical need in the market. Near-term growth is likely driven by capacity expansions and strategic partnerships. The company's ability to maintain regulatory compliance and deliver on complex manufacturing requirements will be key to its success. With no known near-term catalysts, the outlook is moderately positive, contingent on execution and market conditions.

Upcoming Catalysts (preview)

• 2026-01-01T00:00:00ZNew Sterile Manufacturing Capacity Expansion70% success
• TBDMajor Pharma Partnership Announcement60% success
• TBDRegulatory Approval of In-House Developed Combination Product30% success